HDAC9 and lung cancer: Simultaneous application of the dual PI3K/mTOR inhibitor BEZ235 and the HDAC inhibitor trichostatin A (TSA) synergistically suppressed growth and metastasis of lung cancer cells in vitro and in vivo by inactivating both Akt and mTOR and down-regulating HDAC [45].